首页> 美国卫生研究院文献>Journal of Cancer >Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells
【2h】

Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells

机译:白细胞介素37表达抑制STAT3抑制人宫颈癌细胞的增殖和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objectives: The most recently discovered cytokine interleukin 37 (IL-37) received growing attention. Its function on tumor is largely unknown. Here, we investigated the biological function of IL-37 on cervical cancer (CC).>Materials and methods: HPV+ Hela cells and HPV- C33A cells were used. RT-qPCR was performed to detect the transcription of IL-37, STAT3, TNF-αand IL-1β. Western blotting was used for protein detection. CCK-8 assay and transwell assay were employed for cell proliferation and invasion detection, respectively.>Results: Successful gene transfection of IL-37 suppressed the proliferation and invasion of CC. Interestingly, IL-37 showed higher anticancer ability in HPV+ Hela cells than that in HPV- C33A cells. Then, the molecular mechanism of IL-37 anticancer was explored. Firstly, we found that IL-37 inhibited STAT3 expression at both mRNA and protein levels. IL-37 also down regulated the phosphorylation of STAT3. Secondly, blockage of STAT3 using siRNAs reduced significantly the ability of IL-37 to suppress cell proliferation and invasion. Thirdly, STAT3 knockdown reduced markedly the inhibition of IL-37 on the transcription of tumor-derived TNF-α and IL-1β, indicating the contribution of STAT3 for the cancer associated antiinflammation of IL-37. Finally, STAT3 up regulation restored the ability of cell proliferation, cell invasion and the expression of inflammatory cytokines, TNF-α and IL-1β.>Conclusions: IL-37 suppressed cell proliferation and invasion of CC and STAT3 is involved in this process. Thus, IL-37 emerges as a new anticancer cytokine for CC. This study demonstrated a new biological function of IL-37 and offered a potential molecule for CC treatment.
机译:>目标:最近发现的细胞因子白介素37(IL-37)受到越来越多的关注。其对肿瘤的功能很大程度上未知。在这里,我们研究了IL-37对宫颈癌(CC)的生物学功能。>材料和方法:HPV + Hela细胞和HPV -使用了C33A细胞。进行RT-qPCR检测IL-37,STAT3,TNF-α和IL-1β的转录。 Western印迹用于蛋白质检测。 >结果:成功的IL-37基因转染抑制了CC的增殖和侵袭。CCK-8和transwell分别用于细胞增殖和侵袭检测。有趣的是,IL-37在HPV + Hela细胞中显示出比HPV - C33A细胞更高的抗癌能力。然后,探讨了IL-37抗癌的分子机制。首先,我们发现IL-37在mRNA和蛋白水平均抑制STAT3表达。 IL-37还下调STAT3的磷酸化。其次,使用siRNA阻断STAT3会大大降低IL-37抑制细胞增殖和侵袭的能力。第三,STAT3敲低显着降低了IL-37对肿瘤来源的TNF-α和IL-1β转录的抑制作用,表明STAT3对与癌症相关的IL-37抗炎作用。最终,STAT3上调恢复了细胞的增殖,侵袭能力以及炎性细胞因子,TNF-α和IL-1β的表达。>结论:IL-37抑制了CC和STAT3的细胞增殖和侵袭。参与这个过程。因此,IL-37成为CC的新抗癌细胞因子。这项研究证明了IL-37的新生物学功能,并为CC治疗提供了潜在的分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号